During the past decade, Rockford CardioVascular Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rockford CardioVascular Associates" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "W.L.Gore & Associates" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Medtronic Endovascular" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rockford CardioVascular Associates" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rockford CardioVascular Associates" are "Heart Failure" (3 trials), "Arterial Occlusive Diseases" (1 trials), "Brain Diseases" (1 trials), "Cardiovascular Diseases" (1 trials) and "Carotid Artery Diseases" (1 trials). Many other conditions were trialed in "Rockford CardioVascular Associates" in a lesser frequency.

Most popular intervention types in "Rockford CardioVascular Associates" are "Device" (5 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "EverFlex™ Self-Expanding Peripheral Stent System" (1 trials), "Gore Embolic Filter" (1 trials) and "Gore Flow Reversal System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rockford CardioVascular Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Rockford CardioVascular Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Rockford CardioVascular Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rockford CardioVascular Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".